Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Schembri

Showing results (51-60 of 225) with videos related to

Pageof 23
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|January 25, 2016
Co-transcriptomic Analysis by RNA Sequencing to Simultaneously Measure Regulated Gene Expression in Host and Bacterial PathogenTimothy Ravasi, Charalampos Harris Mavromatis, Nilesh J Bokil, et al.
Critical Reviews in Microbiology|January 19, 2018
Bacterial pathogenesis and interleukin-17: interconnecting mechanisms of immune regulation, host genetics, and microbial virulence that influence severity of infectionMichelle N Chamoun, Antje Blumenthal, Matthew J Sullivan, et al.
Infection and Immunity|April 11, 2007
Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tractGlen C Ulett, Jaione Valle, Christophe Beloin, et al.
The Journal of Biological Chemistry|May 17, 2014
Crystal structure of the dithiol oxidase DsbA enzyme from proteus mirabilis bound non-covalently to an active site peptide ligandFabian Kurth, Wilko Duprez, Lakshmanane Premkumar, et al.
The Journal of Antimicrobial Chemotherapy|October 28, 2020
Erratum to: Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infectionsAdam G Stewart, Patrick N A Harris, Andrew Henderson, et al.
Microbiology (Reading, England)|June 30, 2007
The role of F9 fimbriae of uropathogenic Escherichia coli in biofilm formationGlen C Ulett, Amanda N Mabbett, Khe C Fung, et al.
Plos One|October 25, 2013
Human bladder uroepithelial cells synergize with monocytes to promote IL-10 synthesis and other cytokine responses to uropathogenic Escherichia coliBenjamin L Duell, Alison J Carey, Samantha J Dando, et al.
The Journal of Antimicrobial Chemotherapy|February 20, 2020
Uncovering novel susceptibility targets to enhance the efficacy of third-generation cephalosporins against ESBL-producing uropathogenic Escherichia coliMinh-Duy Phan, Amy L Bottomley, Kate M Peters, et al.
The Journal of Antimicrobial Chemotherapy|May 23, 2020
Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infectionsAdam G Stewart, Patrick N A Harris, Andrew Henderson, et al.
Cellular Microbiology|September 25, 2020
An alloy of zinc and innate immunity: Galvanising host defence against infectionJessica B von Pein, Claudia J Stocks, Mark A Schembri, et al.
Pageof 23

Showing results (51-60 of 225) with videos related to

Sort By:
Pageof 23
Methods in Molecular Biology (Clifton, N.J.)|January 25, 2016
Co-transcriptomic Analysis by RNA Sequencing to Simultaneously Measure Regulated Gene Expression in Host and Bacterial PathogenTimothy Ravasi, Charalampos Harris Mavromatis, Nilesh J Bokil, et al.
Critical Reviews in Microbiology|January 19, 2018
Bacterial pathogenesis and interleukin-17: interconnecting mechanisms of immune regulation, host genetics, and microbial virulence that influence severity of infectionMichelle N Chamoun, Antje Blumenthal, Matthew J Sullivan, et al.
Infection and Immunity|April 11, 2007
Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tractGlen C Ulett, Jaione Valle, Christophe Beloin, et al.
The Journal of Biological Chemistry|May 17, 2014
Crystal structure of the dithiol oxidase DsbA enzyme from proteus mirabilis bound non-covalently to an active site peptide ligandFabian Kurth, Wilko Duprez, Lakshmanane Premkumar, et al.
The Journal of Antimicrobial Chemotherapy|October 28, 2020
Erratum to: Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infectionsAdam G Stewart, Patrick N A Harris, Andrew Henderson, et al.
Microbiology (Reading, England)|June 30, 2007
The role of F9 fimbriae of uropathogenic Escherichia coli in biofilm formationGlen C Ulett, Amanda N Mabbett, Khe C Fung, et al.
Plos One|October 25, 2013
Human bladder uroepithelial cells synergize with monocytes to promote IL-10 synthesis and other cytokine responses to uropathogenic Escherichia coliBenjamin L Duell, Alison J Carey, Samantha J Dando, et al.
The Journal of Antimicrobial Chemotherapy|February 20, 2020
Uncovering novel susceptibility targets to enhance the efficacy of third-generation cephalosporins against ESBL-producing uropathogenic Escherichia coliMinh-Duy Phan, Amy L Bottomley, Kate M Peters, et al.
The Journal of Antimicrobial Chemotherapy|May 23, 2020
Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infectionsAdam G Stewart, Patrick N A Harris, Andrew Henderson, et al.
Cellular Microbiology|September 25, 2020
An alloy of zinc and innate immunity: Galvanising host defence against infectionJessica B von Pein, Claudia J Stocks, Mark A Schembri, et al.
Pageof 23